logo-loader
NYSEMKT:VNRX

VolitionRx

Recieve alerts
Market:
NYSEMKT
Market Cap:
$173.81 m
Price
0.00
Change
0.26%
52 weeks high
4.65
52 weeks low
1.67
;

In brief

Volition is a multi-national life sciences company developing simple, easy to use blood-based cancer tests to accurately diagnose a range of cancers. The tests are based on the science of Nucleosomics®, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid -- an indication that disease is present.